Skip to main content

The SDGs for management of related problems in renal replacement therapy

Edited by: Ken Tsuchiya, Tokyo Women’s Medical University, Japan
                 Norio Hanafusa, Tokyo Women’s Medical University, Japan

New Content Item
The 67th Annual Meeting of the Japanese Society for Dialysis Therapy was held under the theme “Seeking SDGs for Dialysis Therapy.” SDGs (Sustainable Development Goals) are the “international development goals for sustainable development,” and we believe that this concept applies directly to dialysis treatment. Sustained efforts are needed to make the necessary changes and to retain what should be preserved. At this conference we would like to identify sustainable goals for dialysis treatment, and together with you, consider the best means of achieving them.

The theme of this thematic series is “seeking SDGs for management of related problems in renal replacement therapy.” Today, the field of dialysis is undergoing a variety of changes. The modality has changed, patient awareness has changed, and the concept of conservative renal therapy without dialysis is gaining ground. Thinking tools such as SDM and ACP are used in the process to reach this conclusion. This process involves not only physicians but also nurses, clinical engineers, and other professionals. On the other hand, the COVID-19 pandemic has made dialysis treatment vulnerable to infectious diseases, as well as to disasters. Although AI may be one way to deal with the various problems regarding dialysis treatment, let us now reaffirm our commitment to identifying the various problems and to achieving these goals through sustained efforts.

All articles have undergone Renal Replacement Therapy’s standard peer review process and have been subject to all of the journal’s standard policies. This includes the journal’s policy on competing interests. The Editors declare no competing interests with the submissions which they have handled through the peer review process. The peer review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.


  1. Traditionally in Japan, dialysis treatment has been performed primarily by physicians and nurses. However, with the advancement of related medical equipment, such as the development of dialyzers and dialysis m...

    Authors: Takashi Honma, Masao Takagi, Junji Uchino and Ken Tsuchiya
    Citation: Renal Replacement Therapy 2024 10:1
  2. In 2022, the government approved the telemedicine system for peritoneal dialysis (PD) in Japan in the form of medical fees. In 2000, we completed a telemedicine system for PD using an automatic peritoneal dial...

    Authors: Hidetomo Nakamoto, Ryutaro Aoyagi, Takeru Kusano, Takehito Kobayashi and Munekazu Ryuzaki
    Citation: Renal Replacement Therapy 2023 9:31
  3. Approximately 340,000 people in Japan are on chronic dialysis, and this number continues to increase. Even today, hemodialysis is the most frequently selected modality for renal replacement therapy in Japan, a...

    Authors: Yuki Kawaguchi, Norio Hanafusa and Ken Tsuchiya
    Citation: Renal Replacement Therapy 2023 9:29
  4. In accordance with the United Nations' 2030 Agenda for Sustainable Development and Japan's Diet Members Caucus on Global Health, we prepared a report and recommendations for nephrology nursing care in the cont...

    Authors: Nadami Mimura, Yoshiko Takuwa, Yui Tamura, Harumi Kawamura, Misato Nishimura and Noriko Yamaguchi
    Citation: Renal Replacement Therapy 2023 9:27
  5. Hemodiafiltration (HDF) therapy has become standard treatment in Japan and Europe, but evidence from Europe is not directly applicable to HDF in Japan because HDF therapy differs greatly in the two regions. Ja...

    Authors: Toshihide Naganuma, Yoshiaki Takemoto, Naohiro Kamada and Hideki Kawanishi
    Citation: Renal Replacement Therapy 2023 9:23
  6. Frailty has become an emerging public health problem in the aging society and is regarded as a state of vulnerability to developing increased dependency and/or mortality when exposed to a stressor. As the prop...

    Authors: Kosaku Nitta, Norio Hanafusa, Yuki Kawaguchi and Ken Tsuchiya
    Citation: Renal Replacement Therapy 2023 9:2

Annual Journal Metrics

  • 2022 Citation Impact
    1.2 - 2-year Impact Factor
    0.703 - SNIP (Source Normalized Impact per Paper)
    0.438 - SJR (SCImago Journal Rank)

    2023 Speed
    12 days submission to first editorial decision for all manuscripts (Median)
    137 days submission to accept (Median)

    2023 Usage 
    545,038 downloads
    139 Altmetric mentions